•Traditional disease activity measures (eg, CDAI) do NOT reflect impaired QoL
•Improvement in QoL is
an important treatment goal
•In the past, clinical
trials in IBD often relied only on traditional
measures
•Validated measures of HRQoL (eg, IBDQ) have been developed for application in clinical IBD
trials
•